| Net (loss) income | -15.83M |
| Loss from discontinued operations | 0 |
| Depreciation and amortization | 599K |
| Provision for (recovery of) doubtful accounts | |
| Stock based compensation expense | 841K |
| Change in fair value of liability-classified warrants | |
| Change in fair value of financial instruments | |
| Amortization of debt discount and accretion of debt payment premium | |
| Amortization of debt issuance costs | |
| (Gain) loss on unconsolidated affiliate | |
| Loss on foreign currency transactions | -813K |
| (Gain) loss on disposal of property and equipment | 20K |
| Gain on sale of intellectual property | |
| Accounts receivable | -1.58M |
| Inventories | -666K |
| Prepaid expenses and other assets | 170K |
| Accounts payable | |
| Income taxes payable | -102K |
| Accrued expenses and other current liabilities | |
| Cash (used in) provided by operating activities of continuing operations | -4.05M |
| Cash used in operating activities of discontinued operations | 0 |
| Net cash (used in) provided by operating activities | -4.05M |
| Purchases of property and equipment | -116K |
| Investment in unconsolidated affiliate | |
| Proceeds from sale of property and equipment | 130K |
| Proceeds from sale of intellectual property | |
| Net cash (used in) provided by investing activities | 14K |
| Net borrowings under demand line of credit | -201K |
| Borrowings under line of credit | |
| Repayment of line of credit | |
| Proceeds from issuance of debt | |
| Proceeds from issuance of shareholder notes payable | |
| Proceeds from exercise of warrants | 247K |
| Payment of settlement obligation | |
| Repayment of capital lease obligations | |
| Payments for debt issuance costs | |
| Net cash provided by (used in) financing activities | 3.8M |
| Effect of exchange rates on cash | -20K |
| Net change in cash and cash equivalents | |
| Cash and cash equivalents at beginning of period | |
| Cash and cash equivalents at end of period | |
| Cash paid for interest | |
| Cash paid for income taxes | |